Back

The efficacy and safety of low-intensity statins for high bleeding risk patients after PCI in Asian populations

29 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Dyslipidaemias: current strategies and innovations Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ze Zhang

Tianjin (China)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor E. Bolsteina (Riga, LV)
Abstract Slides
Presentation thumbnail
Ms H. Shen (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Professor S. Hong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Doctor X. Liu (CH)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Dyslipidaemias: current strategies and innovations

The Event

Event poster

ESC Congress 2025

29 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of low-intensity versus moderate-high-intensity lipid-lowering treatment on outcomes in AMI patients aged 80 and older: a retrospective cohort study
thumbnail
Congress Presentation
Pattern of dual antiplatelet use and 12-month outcomes stratified by bleeding and ischemic risk in acute coronary syndrome patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
The impact of high-intensity statin on 3-year clinical outcomes in elderly acute myocardial infarction patients underwent percutaneous coronary intervention with drug-eluting stents

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources